Loading...
XLONHYG
Market cap4mUSD
Nov 15, Last price  
11.50GBP
Name

Seneca Growth Capital VCT PLC

Chart & Performance

D1W1MN
XLON:HYG chart
P/E
P/S
EPS
Div Yield, %
0.21%
Shrs. gr., 5y
28.32%
Rev. gr., 5y
%
Revenues
-2m
L-6.00%
000000005,224,00011,00012,000-1,352,000-599,000-340,000179,000-592,0001,449,0002,267,000-2,551,000-2,398,000
Net income
-3m
L-2.84%
-6,000-324,000-167,000-164,000-123,000-17,000-134,000-86,0003,861,000-164,000-151,000-1,205,000-582,000-367,00066,000-715,0001,297,0002,096,000-2,749,000-2,671,000
CFO
-459k
L-4.57%
454,000-213,000-390,000-122,000-173,00021,000-418,000228,000-157,000-205,000-78,000-152,000-132,000-109,000-106,000-138,000-194,000-288,000-481,000-459,000
Dividend
May 04, 20232 GBP/sh
Earnings
Mar 20, 2025

Profile

Seneca Growth Capital VCT plc is a venture capital trust specializes in growth capital. It invests in emerging biotechnology companies. It prefers to invest in unquoted and quoted MedTech companies. The fund seeks to invest in the United Kingdom, IIe-de-France, Burgundy, France, European Developed Markets. It typically invests in companies with sales greater than £10 million ($11.90 million), gross margin greater than 50% and operating margin greater than 10%.
IPO date
Apr 19, 2002
Employees
0
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
(2,398)
-6.00%
(2,551)
-212.53%
2,267
56.45%
Cost of revenue
252
485
540
Unusual Expense (Income)
NOPBT
(2,650)
(3,036)
1,727
NOPBT Margin
110.51%
119.01%
76.18%
Operating Taxes
(2,749)
2,096
Tax Rate
121.37%
NOPAT
(2,650)
(287)
(369)
Net income
(2,671)
-2.84%
(2,749)
-231.15%
2,096
61.60%
Dividends
(791)
(700)
(727)
Dividend yield
Proceeds from repurchase of equity
2,224
3,816
5,470
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
146
168
516
Net debt
(13,318)
(18,641)
(18,270)
Cash flow
Cash from operating activities
(459)
(481)
(288)
CAPEX
Cash from investing activities
(688)
(4,675)
(2,406)
Cash from financing activities
1,433
3,116
4,743
FCF
(2,650)
(287)
(369)
Balance
Cash
1,455
5,065
7,105
Long term investments
11,863
13,576
11,165
Excess cash
13,438
18,769
18,157
Stockholders' equity
299
9,666
7,025
Invested Capital
16,739
8,985
11,254
ROIC
ROCE
9.45%
EV
Common stock shares outstanding
28,232
16,231
20,118
Price
Market cap
EV
EBITDA
(2,650)
(3,036)
1,727
EV/EBITDA
Interest
Interest/NOPBT